1.
Gastrointest Endosc Clin N Am
; 21(1): 155-70, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21112505
RESUMO
Esophageal adenocarcinoma is increasing in incidence. The main risk factor is the premalignant condition of Barrett's esophagus. There is great interest in chemoprevention to prevent or slow malignant transformation. There are many agents proposed as playing a role in chemoprevention; however, none is licensed for this role as yet. Aspirin possesses many favorable qualities for chemoprevention and is the focus of the largest randomized control trial in this field.